אולנזאפין דקסל 5 מ"ג

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

OLANZAPINE 5 MG

Disponible des:

DEXCEL PHARMA TECHNOLOGIES LTD

Codi ATC:

N05AH03

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricat per:

DEXCEL LTD

Grupo terapéutico:

OLANZAPINE

indicaciones terapéuticas:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Data d'autorització:

2012-05-01